Gender
Phosphodiesterase Inhibitors (SHHS2) vs SHHS Visit Number
| Visit 1 | Interim Follow-up Visit | Visit 2 | CVD Outcomes | |
|---|---|---|---|---|
| Total | - | - | 4,080 | - |
| No | - | - | 3,555 | - |
| Yes | - | - | 65 | - |
| Don't know | - | - | - | - |
| Unknown | - | - | 460 | - |
Phosphodiesterase Inhibitors (SHHS2) vs Age at SHHS1
Visit 2
| 35-44 years | 45-54 years | 55-64 years | 65-74 years | 75-84 years | 85 years or older | Total | |
|---|---|---|---|---|---|---|---|
| Total | 184 | 707 | 1,321 | 1,200 | 624 | 44 | 4,080 |
| No | 175 | 641 | 1,136 | 1,030 | 533 | 40 | 3,555 |
| Yes | 1 | 6 | 12 | 26 | 20 | - | 65 |
| Don't know | - | - | - | - | - | - | - |
| Unknown | 8 | 60 | 173 | 144 | 71 | 4 | 460 |
Phosphodiesterase Inhibitors (SHHS2) vs Gender
Visit 2
| Male | Female | Total | |
|---|---|---|---|
| Total | 1,861 | 2,219 | 4,080 |
| No | 1,635 | 1,920 | 3,555 |
| Yes | 26 | 39 | 65 |
| Don't know | - | - | - |
| Unknown | 200 | 260 | 460 |
Phosphodiesterase Inhibitors (SHHS2) vs Race
Visit 2
| White | Black | Other | Total | |
|---|---|---|---|---|
| Total | 3,587 | 256 | 237 | 4,080 |
| No | 3,107 | 232 | 216 | 3,555 |
| Yes | 55 | 10 | - | 65 |
| Don't know | - | - | - | - |
| Unknown | 425 | 14 | 21 | 460 |